This study will provide a comprehensive assessment of long-term treatment with the ketogenic diet, a medical diet with high fat and low carbohydrate intake, focusing on safety and cardiovascular implications. We will assess patients with epilepsy or one of two rare metabolic diseases; glucose transporter type 1 deficiency syndrome (GLUT1 DS) or pyruvate dehydrogenase complex deficiency (PDHD).
Study Type
OBSERVATIONAL
Enrollment
30
Examinations carried out according to the American Society of Echocardiography guidelines 25 using a Vivid 7 US instrumentation with a linear M12L probe (14 MHZ; General Electric).
Oslo University Hospital
Oslo, Norway
Cardiovascular risk after long-term treatment with the ketogenic diet
Color duplex ultrasound
Time frame: 2018-2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.